Accendra HealthACH +5.36%57 Days Payable is 96.32 as of Mar. 2026, which is 114% above its 10-year median of 45.01. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 117 Medical Distribution companies, Accendra Health ranks better than 84.62% on this metric.
The historical rank and industry rank for Accendra Health's Days Payable or its related term are showing as below:
ACH'
s Days Payable Range Over the Past 10 Years
Min: 31.24 Med: 45.01 Max: 316.93
Current: 140.04
During the past 13 years, Accendra Health's highest Days Payable was 316.93. The lowest was 31.24. And the median was 45.01.
ACH's Days Payable is ranked better than 84.62% of 117
companies
in the Medical Distribution industry
Industry Median: 79.11
vs ACH: 140.04
Accendra Health's Days Payable
increased
from Mar. 2025 (37.71) to Mar. 2026 (96.32).
It may suggest that Accendra Healthdelayed paying its suppliers.
Accendra Health Days Payable Related Terms
Accendra Health Days Payable Historical Data
* Premium members only.
The historical data trend for Accendra Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Accendra Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Accendra Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a Days Payable of 96.32 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Accendra Health and its competitors. This is 114% above median its historical median of 45.01. Over the past decade, Accendra Health's Days Payable has ranged from 31.24 to 316.93. According to the industry distribution chart, Accendra Health ranks #18 out of 117 companies in the Medical Distribution industry, placing it in the top 15.4%.
Is Accendra Health's Days Payable too high?
Accendra Health's current Days Payable of 96.32 is 114% above median its 10-year median of 45.01. Over the past 10 years, this metric has ranged from a low of 31.24 to a high of 316.93. The Medical Distribution industry median Days Payable is 79.11. Accendra Health's value of 96.32 is 21.8% above this industry median. Based on the distribution chart, Accendra Health ranks #18 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Days Payable compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #18 out of 117 companies for Days Payable. This places Accendra Health in the top 15% of its industry — outperforming the majority of peers. The industry median Days Payable is 79.11. Accendra Health's value of 96.32 is 21.8% above this benchmark. Historically, Accendra Health's own Days Payable has ranged from 31.24 to 316.93 over the past decade. While the company's 10-year median is 45.01 vs. the industry median of 79.11, Accendra Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current Days Payable of 96.32 is 21.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current Days Payable is 96.32, which is 114% above median its own 10-year median of 45.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.34 — trading 33.5% below its estimated fair value. The current Days Payable is 96.32, which is 114% above median its 10-year median of 45.01 and 21.8% above the Medical Distribution industry median of 79.11. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Accendra Health (ACH), the current Days Payable is 96.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.34 is trading 33.5% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Days Payable: 96.32 (114% above median its 10-year median of 45.01)
GF Value™: $5.02 vs. price of $3.34 (33.5% below fair value)
Industry Position: 21.8% above the Medical Distribution median (#18 of 117)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
